Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.

被引:0
|
作者
Kim, Richard D.
Pan, Xiaoyun
Ostojic, Helene
Zhang, Yiqiao
Lunacsek, Orsolya
Pisa, Federica
Peeters, Marc
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Bayer HealthCare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ USA
[3] Bayer Consumer Care AG, Basel, Switzerland
[4] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[5] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[6] Antwerp Univ, Antwerp Univ Hosp, Edegem, Belgium
关键词
281-5277-2622-5397; 281-318-9499; 283-237-255; 3282-206-4957-326-5009-2386; 4; 3; 2; 182; 250; 38092-25821; 38092-20285; 38092-18849;
D O I
10.1200/JCO.2024.42.3_suppl.48
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:48 / 48
页数:1
相关论文
共 50 条
  • [31] Colorectal cancer surgery in octogenarians: real-world long-term results
    Willemsen, Paul
    Devriendt, Stefanie
    Heyman, Stijn
    Van Fraeyenhove, Frank
    Perkisas, Stany
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 409 (01)
  • [32] Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"
    Coutzac, Clelia
    Trouilloud, Isabelle
    Pascal, Artru
    Henriques, Julie
    Masson, Therese
    Doat, Solene
    Bouche, Olivier
    Coriat, Romain
    Saint, Angelique
    Moulin, Valerie
    Vernerey, Dewi
    Gallois, Claire
    De La Fouchardiere, Christelle
    Tougeron, David
    Taieb, Julien
    CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 132 - 140
  • [33] Regorafenib Combined With PD-1 Inhibition as Salvage Treatment and in a Real-World Study of Patients with Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 7 - 7
  • [34] Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world study
    Huang, Jinglong
    Gong, Caifeng
    Jiang, Zhichao
    Qu, Wang
    Sun, Yongkun
    Teo, Nan Zun
    Zhang, Wen
    Yang, Lin
    Zhao, Yunbo
    Zhou, Aiping
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05)
  • [35] Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
    Yeh, Kun-Huei
    Yang, Tsai-Sheng
    Hsu, Tzu-Chi
    Chen, William Tzu-Liang
    Chen, Hong-Hwa
    Teng, Hao-Wei
    Lin, Bo-Wen
    Kuan, Feng-Che
    Chiang, Feng-Fan
    Duann, Chi-Wei
    Li, Ying-Shiuan
    Lin, Meng-Ting
    Fiala-Buskies, Sabine
    Ducreux, Michel
    Wang, Jaw-Yuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (11) : 2023 - 2031
  • [36] Pharmacokinetics of regorafenib (REG) in the phase 3 CONCUR and CORRECT trials in patients (pts) with metastatic colorectal cancer (mCRC)
    Cleton, A.
    Sturm, I.
    Trnkova, Z. Jirakova
    Grevel, J.
    Fiala-Buskies, S.
    Lettieri, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 10 - 10
  • [37] Comparison of the real-world adherence and compliance patterns with trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) for the treatment of metastatic colorectal cancer (mCRC).
    Patel, Anuj K.
    Duh, Mei Sheng
    Barghout, Victoria
    Yenikomshian, Mihran Ara
    Xiao, Yongling
    Wynant, Willy
    Tabesh, Majid
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort
    Metges, Jean-Philippe
    Genet, Dominique
    Tougeron, David
    Ligeza, Catherine
    Ducreux, Michel
    Borg, Christophe
    Guimbaud, Rosine
    Phelip, Jean-Marc
    Dourthe, Louis-Marie
    Kim, Stefano
    FUTURE ONCOLOGY, 2021, 17 (25) : 3343 - 3353
  • [39] REAL-WORLD TREATMENT PATTERNS, SEQUENCING, AND UNMET NEED IN METASTATIC COLORECTAL CANCER (MCRC)
    Desai, K.
    Shao, C.
    Li, S.
    Hair, G. M.
    Liu, L.
    Jain, R.
    Amonkar, M.
    VALUE IN HEALTH, 2024, 27 (06) : S183 - S183
  • [40] Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting
    Yamaguchi, Kensei
    Komatsu, Yoshito
    Satoh, Taroh
    Uetake, Hiroyuki
    Yoshino, Takayuki
    Nishida, Toshirou
    Yamazaki, Naoya
    Takikawa, Haiime
    Morimoto, Takashi
    Chosa, Masayuki
    Sunaya, Toshiyuki
    Hamada, Yoko
    Muro, Kei
    Sugihara, Kenichi
    ONCOLOGIST, 2019, 24 (07): : E450 - E457